Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005)

International Journal of Gynecological Cancer

Volumn 18, Issue 5, 2008, Pages 916-920

  Lee, J K ^a   Song, S H ^a   Kim, I ^a   Lee, K H ^b   Kim, B G ^c   Kim, J W ^d   Kim, Y T ^e   Park, S Y ^f   Cha, M S ^g   Kang, S B ^d  

^a Korea University College of Medicine   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f National Cancer Center   (South Korea)

^g Dong A University College of Medicine   (South Korea)

Author keywords

Pseudomyxoma peritonei; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; MITOMYCIN; PACLITAXEL;

ADOLESCENT; ADULT; AGED; APPENDECTOMY; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; MULTICENTER STUDY; OVARY TUMOR; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 51749088587     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01146.x     Document Type: Article

References (26)

1. Mann WJ Jr., Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer 1990 66 : 1636 40.
2. Hopkins ML, Depetrillo AD, Le T, Fung MF. Pseudomyxoma peritonei: a case series and review of the literature. Int J Gynecol Cancer 2005 15 : 32 6.
3. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 1995 19 : 1390 408.
4. Sherer DM, Abulafia O, Eliakim R. Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest 2001 51 : 73 80.
5. Galani E, Marx GM, Steer CB, Culora G, Harper PG. Pseudomyxoma peritonei: the 'controversial' disease. Int J Gynecol Cancer 2003 13 : 413 8.
6. Wertheim I, Fleischhacker D, McLachlin CM, Rice LW, Berkowitz RS, Goff BA. Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol 1994 84 : 17 21.
7. Fernandez RN, Daly JM. Pseudomyxoma peritonei. Arch Surg 1980 115 : 409 14.
8. Kim HS, Park KA, Lee HJ et al. Clinical analysis of the effect to survival by FIGO stage and surgical treatment combined with chemotherapy in patients with pseudomyxoma peritonei. Korean J Gynecol Oncol 2006 17 : 157 66.
9. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001 92 : 85 91.
10. Miner TJ, Shira J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005 241 : 300 8.
11. Nasr MF, Kemp GM, Given FT Jr. Pseudomyxoma peritonei: treatment with intraperitoneal 5-fluorouracil. Eur J Gynaecol Oncol 1993 14 : 213 7.
12. Hsieh SY, Chiu CT, Sheen IS, Lin DY, Wu CS. A clinical study on pseudomyxoma peritonei. J Gastroenterol Hepatol 1995 10 : 86 91.
13. Alexander-Sefre F, Chandrakumaran K, Banerjee S, Sexton R, Thomas JM, Moran B. Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis 2005 7 : 382 6.
14. Kuo CM, Kuo CH, Changchien CS, Chin KW, Hsu TT. Pseudomyxoma peritonei with high serum CA 19-9: report of three cases. Changgeng Yi Xue Za Zhi 1999 22 : 94 9.
15. van Ruth S, Hart AA, Bonfrer JM, Verwaal VJ, Zoetmulder FA. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2002 9 : 961 7.
16. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998 85 : 1332 9.
17. Ronnett BM, Kurman RJ, Zahn CM et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995 26 : 509 24.
18. Lee JJ, Jung HY, Jung YS et al. A case of pseudomyxoma peritonei. Korean J Obstet Gynecol 2002 45 : 2307 11.
19. Park JH, Yang YH, Han YH. A clinicopathologic analysis of pseudomyxoma peritonei originated from mucinous ovarian tumors. Korean J Obstet Gynecol 1999 42 : 1808 14.
20. Jung JK, Chon CY, Cho HG et al. A clinical review of pseudomyxoma peritonei. Korean J Gastroenterol 1997 30 : 323 32.
21. Sugarbaker PH, Ronnett BM, Archer A et al. Pseudomyxoma peritonei syndrome. Adv Surg 1996 30 : 233 80.
22. Gough DB, Donohue JH, Schutt AJ et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994 219 : 112 9.
23. Witkamp AJ, de Bree E, Kaag MM et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001 37 : 979 84.
24. Moran BJ. Establishment of a peritoneal malignancy treatment centre in the United Kingdom. Eur J Surg Oncol 2006 32 : 614 8.
25. Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1992 70 : 396 401.
26. Huang HC, Huang YS, Shyr YM, Yen SH, Chang FY, Lee SD. Clinical experience of pseudomyxoma peritonei in Taiwan with emphasis on the treatment and survival. Hepatogastroenterology 2002 49 : 999 1001.